Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-

Product Name
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
CAS No.
149839-65-6
Chemical Name
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
Synonyms
Etoposide EP impurity R (S configuration);Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...;Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
CBNumber
CB49812158
Molecular Formula
C50H50O20
Formula Weight
970.93
MOL File
149839-65-6.mol
More
Less

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Property

Density 
1.58±0.1 g/cm3(Predicted)
pka
9.94±0.40(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Suppliers

TOSUN PHARM
Tel
61855200 13326451905
Email
3003386889@qq.com
Country
China
ProdList
7942
Advantage
58
Hubei Xinyang Medical Technology Co., Ltd
Tel
15347293736
Fax
QQ:2853117752
Email
2853117764@yongstandards.com
Country
China
ProdList
10000
Advantage
58
Henan Vcommend Consultrading Co., Ltd.
Tel
13393721940
Email
sales@vcommend.com
Country
China
ProdList
9963
Advantage
58
ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel
13986652530
Email
zhangweiyue@hdimpurity.com
Country
China
ProdList
7993
Advantage
58
Cato Research Chemicals Inc.
Tel
020-81960175-877 18933936954
Email
2853283383@qq.com
Country
China
ProdList
11421
Advantage
58
Chengdu Peter-like Biotechnology Co., Ltd.
Tel
028-81700200 13308200041
Email
2851167782@qq.com
Country
China
ProdList
11143
Advantage
58
Hubei Rhema Reference Materials Technology Co., Ltd.
Tel
15787879035 15787875101
Email
ydw9035@rmastandards.com
Country
China
ProdList
9680
Advantage
58
Moxin Chemicals
Tel
+86-17320513646 +8617320513646
Email
anna@molcoo.com
Country
China
ProdList
10000
Advantage
58

149839-65-6, Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-Related Search:


  • Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
  • Etoposide EP impurity R (S configuration)
  • Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...
  • 149839-65-6